I really don't want to be a doctor

Chapter 489 Prospective Graduates
Bang bang bang!
Just as the two were talking, there was a knock on the door.

"Please come in!" Jing Xiaoran said.

As soon as the words fell, Zhu Xianqing pushed the door open and entered.

"Mr. Zhu, I happen to have something to discuss with you." Jing Xiaoran said with a smile.

Zhu Xianqing walked into the office, holding a thick stack of papers in his hand.

"Ms. Zhu, he is Jin Miao, a good friend of mine." Jing Xiaoran introduced to the two, "Jin Zi, this is Mr. Zhu, he is the director of our laboratory and the director of clinical trials of immune checkpoint inhibitors. principal."

"Hello, Teacher Zhu." Jin Miao nodded slightly.

Zhu Xianqing also nodded in response.

"That's right. Teacher Zhu, I want to temporarily recruit a patient to join our clinical trial. The patient is a friend of Jin Miao." Jing Xiaoran said, "The female patient is currently diagnosed with advanced gastric cancer and has already undergone surgery and surgery. Chemotherapy, now the tumor has relapsed, and severe bone marrow transplantation occurred in the conventional chemotherapy regimen, so now I want to try immunotherapy."

Immediately afterwards, Jing Xiaoran asked Jin Miao to briefly inform Zhu Xianqing of the patient's information.

Hearing this, Zhu Xianqing said: "Then let the patient do a gene target screening first. If there is immune gene expression, then they can be directly enrolled. The tumor hospital should have our experimental group, and then sign the informed consent form." , I will distribute the experimental drug over there.”

"Then thank you Teacher Zhu." Jin Miao smiled.

"Well, you give me a copy of all the patient's information." Zhu Xianqing said, "I want to compare the detailed information, and then let the clinical experimenter connect with the patient."

Jin Miao glanced at Xiao Ran secretly, seeing that he didn't respond, he said, "Well, I'll leave Teacher Zhu's contact information later, and I'll send her information to you."

After staying in the office for a while, Jin Miao saw that Zhu Xianqing came to Jing Xiaoran to discuss something, so he left the laboratory first.

After Jin Miao left, Zhu Xianqing handed the watch to Jing Xiaoran.

"Xiao Ran, look at these tables, which are about our immune checkpoint inhibitor experimental group."

"This is..." Jing Xiaoran took the form and looked at it intently, "Are they all forms for applying to join the clinical trial?"

Zhu Xianqing nodded and said, "All of them are patients who want to join our clinical trials."

Jing Xiaoran roughly counted, there are about 40 application forms, that is, more than 40 patients want to join the clinical trial.

"There are so many?"

In the beginning of the clinical trials of immune checkpoint inhibitors, there was no way to recruit experimental patients. Jing Xiaoran was still worried about this for a while.

But now, even though the experimental patients have been saturated, there are still patients applying to join the experimental project team.

Zhu Xianqing said: "Because our experimental center had a few cases with relatively good curative effect, such as the patient with melanoma named Ke Zunyu in the central hospital, and your friend's mother Liu Shufen, and after media publicity, everyone I have a better understanding of our drug. Now that the prevalence of tumors is so high, and our clinical trials are free of charge, all patients, regardless of whether they have money or not, try to find ways to join our clinical trials.”

In the course of clinical trials throughout the year, immune checkpoint inhibitors, a brand new "anti-tumor drug", are entering the general public's field of vision.

Jing Xiaoran said: "Mr. Zhu, we are running out of experimental drugs. Please send a notice to suspend all clinical trial applications."

"Then what about the forty applications?" Zhu Xianqing asked.

"This..." Jing Xiaoran paused, and put the form in his hand on the table, "Do genetic screening first, then select patients who meet the criteria, and treat this as the last batch of experimental patients. Before our drug was launched Before that, the acceptance of any experimental patients was suspended."

"Well, okay." Zhu Xianqing nodded, "I have already calculated that the remaining drug reserves can support the clinical trial dosage of 40 patients at most, and I will choose the 20 who best meet the standards among the [-] people. people, and include them in the experimental project team.”

"Okay, Mr. Zhu, you can arrange this." Jing Xiaoran said.

……

approaching graduation.

Shenzhou Laboratory originally had many interns from Ning'an Medical College, but now they have all returned to school and started to prepare for graduation procedures.

Of course, this does not include the prospective graduate, Hong Sheng.

As an undergraduate student, he has published several first-author papers in top journals. Before he graduated, Hong Sheng had already received invitations for graduate students from various top universities in the country.

As long as Hong Sheng is willing, he can enter various colleges and universities for further study as an exempt student.

However, his current main research direction is myocardial mesenchymal stem cells. This research topic is top-notch in the world, let alone in China.

However, if Hong Sheng leaves the Shenzhou Laboratory, other laboratories in China will not be able to provide a matching experimental environment, which means that Hong Sheng has voluntarily given up this research and development direction.

This is also one of the reasons why Hong Sheng has never accepted invitations from major universities.

When Jing Xiaoran came to the laboratory of Hong Sheng and Jeffrey, they were having a heated discussion about the experiment.

I just heard Jeffrey say: "Hong, you are wrong. The enzyme activity temperature required for this branch experiment should be controlled at around 80 degrees Celsius."

"Mr. Jeffrey, I have done comparative experiments. The most appropriate temperature should be around 65 degrees Celsius. When it reaches 80 degrees Celsius, the enzyme activity will be inhibited, resulting in slower experimental efficiency..."

Jing Xiaoran walked into the laboratory openly, but the two of them still didn't realize it.

When the two of them finished arguing and Hong Sheng began to arrange the experimental equipment, he found Jing Xiaoran standing aside.

"Ah, monitor, when did you come in..."

"Jing, you're here." Jeffrey also noticed Jing Xiaoran beside him.

"It's been a while since I came in." Jing Xiaoran smiled, "I've been watching the two of you discussing."

"Jing, then hurry up and comment." Jeffrey said hastily, "Do you think there is a problem with any of our experimental procedures?"

Hong Sheng also nodded quickly, and quickly handed over the experiment notebook.

Jing Xiaoran was stunned for a while, and didn't take the lab notebook. He smiled and said, "You two are embarrassing me. I haven't done related experiments, but I can't explain why. We still need real experiments. The data speaks for itself.”

The scientific research barriers between different disciplines are very high, not to mention, Hong Sheng and Jeffrey have been working in the field of intermyocardial stem cells for so long, and Jing Xiaoran really has no say in their experiments .

"However, from my experience, sometimes there is more than one optimum activation temperature, it may be an interval, or it may be a curve." Jing Xiaoran said, "We just need to do a few more experiments for comparison."

Hong Sheng and Jeffrey nodded one after another, both looking thoughtful.

"Squad leader, why do you have time to come to our laboratory today? The clinical trials of immune checkpoint inhibitors are over?" Hong Sheng said suddenly.

"It's not over yet." Jing Xiaoran smiled at Hong Sheng, "I'm here to find you."

"Looking for me?" Hong Sheng asked in surprise.

"Ah."

Hearing this, Jeffrey stood up and prepared to leave, wanting to give the two of them a chance to be alone.

"Jeffrey, you don't have to go, it's not a secret." Jing Xiaoran said.

(End of this chapter)